cdp ethanolamine has been researched along with oleic acid in 1 studies
| Studies (cdp ethanolamine) | Trials (cdp ethanolamine) | Recent Studies (post-2010) (cdp ethanolamine) | Studies (oleic acid) | Trials (oleic acid) | Recent Studies (post-2010) (oleic acid) |
|---|---|---|---|---|---|
| 59 | 0 | 12 | 8,768 | 248 | 3,051 |
| Protein | Taxonomy | cdp ethanolamine (IC50) | oleic acid (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, RA; Igal, RA | 1 |
1 other study(ies) available for cdp ethanolamine and oleic acid
| Article | Year |
|---|---|
Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phospholipid metabolism.
Topics: Cells, Cultured; Choline; Cytidine Diphosphate; Cytidine Diphosphate Choline; Diglycerides; Ethanolamine; Ethanolamines; Fibroblasts; Glycerol; Homeostasis; Humans; Lipid Metabolism, Inborn Errors; Oleic Acid; Phosphatidylcholines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Sphingomyelins; Triglycerides | 1998 |